1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt has been researched along with Bladder Disorder, Neurogenic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sussman, BJ | 1 |
| Berkson, B; Firfer, R; Primack, ML; Zakhary, MG | 1 |
1 review(s) available for 1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt and Bladder Disorder, Neurogenic
| Article | Year |
|---|---|
Inadequacies and hazards of chymopapain injections as treatment for intervertebral disc disease.
Topics: Adult; Animals; Arachnoiditis; Back Pain; Cats; Cerebrovascular Disorders; Chymopapain; Dogs; Drug Hypersensitivity; Endopeptidases; Headache; Hemiplegia; Humans; Inflammation; Intervertebral Disc; Intervertebral Disc Displacement; Paraplegia; Rabbits; Sensation; Spasm; Subarachnoid Hemorrhage; Syndrome; Urinary Bladder, Neurogenic | 1975 |
1 other study(ies) available for 1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt and Bladder Disorder, Neurogenic
| Article | Year |
|---|---|
Urological complications following chemonucleolysis.
Topics: Chymopapain; Drug Hypersensitivity; Endopeptidases; Humans; Hyperesthesia; Hypesthesia; Intervertebral Disc Displacement; Male; Middle Aged; Penile Diseases; Perineum; Urinary Bladder, Neurogenic | 1985 |